Text and Data Mining valid from 2019-10-04
First Online: 4 October 2019
Compliance with Ethical Standards
: This study was sponsored by Alkermes, Inc., which is a pharmaceutical company developing OLZ/SAM, a combination product of olanzapine and samidorphan for the treatment of schizophrenia.
: Lei Sun, Sergey Yagoda, Baiyun Yao, Christine Graham, and Lisa von Moltke are employees of Alkermes, Inc.
: The study was designed and carried out in accordance with the principles of Good Clinical Practice that have their origin in the Declaration of Helsinki and its amendments and in accordance with local regulations and International Conference on Harmonisation guidelines. The study protocol and informed consent forms were approved by the clinical site’s institutional review board prior to any subjects being enrolled into the study.
: All subjects provided written informed consent before participating in the study.